Neural cardiovascular control and hypertension.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001340:Autonomic Nerve Block; D001341:Autonomic Nervous System / Q000503:physiopathology*; D001775:Blood Circulation; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000503:physiopathology; D002490:Central Nervous System / Q000503:physiopathology*; D004027:Diencephalon / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D000860:Hypoxia / Q000473:pathology; D008032:Limbic System / Q000503:physiopathology; D008526:Medulla Oblongata / Q000503:physiopathology; D008954:Models, Biological; D009475:Neurons, Afferent; D009476:Neurons, Efferent; D011149:Pons / Q000503:physiopathology; D011311:Pressoreceptors / Q000503:physiopathology; D011817:Rabbits; D012018:Reflex; D012083:Renin / Q000097:blood; D014655:Vascular Resistance / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001285:Atropine; D012083:Renin